Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘McGuireWoods’ returned 3,654 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    New York, Zombie Debt And The CFPB

    Earlier this month, New York adopted enhanced consumer debt collection regulations proposed by the New York State Department of Financial Services (NYDFS).
    United StatesFinance and Banking
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Reverse Mortgages May Be On CFPB's List Following Recent Study

    In a new study, the Consumer Financial Protection Bureau (CFPB) criticizes reverse mortgages as misleading and as having resulted in senior citizens being confused about exactly what such a transaction involves.
    United StatesFinance and Banking
    McGuireWoods LLP
    McGuireWoods LLP
Article

SBA Final Rule: SBIC Funds May Invest In Double Holding Company Structures

Effective November 20, 2014, an SBIC fund may now utilize two levels of passive small businesses as pass-through entities before the investment proceeds flow through to an eligible subsidiary that qualifies as a small business.
United StatesFinance and Banking
McGuireWoods LLP
McGuireWoods LLP
  • Article

    SBA Issues June 19 Call Notice For Track 2 Early Stage Fund Managers

    In connection with the U.S. Small Business Administration’s (SBA) commitment of up to $1 billion in available leverage to Early Stage Small Business Investment Company (SBIC) Funds over a five year period,
    United StatesFinance and Banking
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    SBA Issues May 25 Call Notice For Early Stage Fund Managers

    In connection with the United States Small Business Administration’s (SBA) commitment of up to $1 billion in available leverage to Early Stage SBIC funds over a five-year period, SBA has issued a call notice for Early Stage fund managers interested in forming a Small Business Investment Company fund to be licensed as an Early Stage SBIC fund.
    United StatesFinance and Banking
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    The CFPB Strongly Scrutinizes MSAs Under RESPA

    The Consumer Financial Protection Bureau (CFPB) recently provided guidance discouraging mortgage industry participants from entering into marketing services arrangements (MSAs).
    United StatesFinance and Banking
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Aetna To Acquire Humana For $37 Billion

    Aetna will acquire Humana for a combination of cash and stock valued at $37 billion, according to a joint news release from the two insurers.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Another Attempt At A National Drug Track-And-Trace Proposal: Three Key Points

    After a nationwide drug tracking system failed to be included into the FDA user fee legislation passed in July 2012, legislation was re-introduced on Wednesday, Oct. 24, 2012, to create a nationwide drug tracking system at the lot level.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Antimicrobial Sales And Distribution Information FDA Proposes To Be Collected By Animal Species

    On May 19, 2015, FDA published in the Federal Register proposed a rule to collect antimicrobial sales and distribution data by major food animal species (cattle, swine, chickens, and turkeys).
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Are Venture Capitalists Primed for Increased Activity in 2011?

    In a recent survey by the National Venture Capital Association and Dow Jones VentureSource, a majority of U.S. venture capitalists stated they are optimistic for 2011 and plan to expand investments generally.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Arlington County, Virginia, To Consider Expediting Outdoor Cafe Approvals

    On June 13, 2023, the Arlington County Board adopted a request to advertise the Future of Outdoor Dining (FOOD) study.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Caronia: Second Circuit Finds FDA’s Off-Label Promotion Ban Unconstitutional

    On Dec. 3, 2012, the U.S. Court of Appeals for the Second Circuit decided in a split decision that the FDA rule banning pharmaceutical manufacturers from truthfully and accurately speaking about a drug’s unapproved uses ("off-label promotion") was a violation of the First Amendment and an individual’s freedom of speech.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    CMS Finalizes Rules For ESRD Dialysis Payment System And Incentive Program

    Private equity investors continue to be active investors in the dialysis industry, as we’ve frequently discussed in the past, including in the Law360 report on "Private Equity Interest in the Dialysis Sector Continues to Thrive" that can be accessed here.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Comvest Partners Closes PE Fund At $893 Million

    Comvest Partners has announced the close of its fifth PE fund.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Congress Continues Work Toward SGR Fix

    Every year since 2002, Congress has postponed the Medicare physician payment cuts that would be triggered by the sustainable growth rate formula.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Congress Expands Medicare Coverage For Acute Dialysis Services

    On June 29, 2015, President Obama signed into law the Trade Preferences Extension Act of 2015, which provides for Medicare reimbursement for renal dialysis services furnished to individuals with acute kidney injury.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Congress Passes Last-Minute Fix To Save FDA Generic Drug User Fee Funds, Leaves Unaddressed Device User Fee Funds

    In a last-minute bid to save the generic drug user fee program, the Senate approved a bill that will allow the Food and Drug Administration to begin collecting new generic drug user fees on Oct. 1.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    DaVita Agrees To $350 Million Settlement To Resolve Illegal Kickbacks Allegations

    DaVita Healthcare Partners has agreed to pay $350 million to resolve claims it violated the False Claims Act, according to a Department of Justice press release.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    FDA Provides New Resource On Redundancy Risk Management Plans For Critical Food Manufacturers

    On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) published a new resource for manufacturers of critical foods...
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Health Care Fraud And Abuse Enforcement

    Several hospitals and health systems have recently settled Anti-Kickback Statute, Stark Law and False Claims Act allegations with the Department of Justice.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Showing 961–980 of 3654 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics